SCHEMBL19232136

SCHEMBL19232136

CC(N)(N)CCC(N)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 6/20 0.48
GSR P00390 2/20 0.48
GRM8 O00222 1/20 0.48
GRM6 O15303 1/20 0.48
GRIN2D O15399 1/20 0.48
GRIN3B O60391 1/20 0.48
CYP1A2 P05177 1/20 0.48
GRIK1 P39086 1/20 0.48
GRM5 P41594 1/20 0.48
GRIA1 P42261 1/20 0.48
GRIA2 P42262 1/20 0.48
GRIA3 P42263 1/20 0.48
SLC1A3 P43003 1/20 0.48
SLC1A2 P43004 1/20 0.48
SLC1A1 P43005 1/20 0.48
GRIA4 P48058 1/20 0.48
GRIN1 Q05586 1/20 0.48
GRIN2A Q12879 1/20 0.48
GRIK2 Q13002 1/20 0.48
GRIK3 Q13003 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21861898 0.89 GSR (0.54) GSRGRM8GRM6GRIN2DGRIN3B
SCHEMBL19232133 0.85 GSR (0.55) GSRCYP1A2GRIK1SLC1A2SLC1A1
SCHEMBL14420362 0.84 KIF11 (0.50) KIF11GSRGRM8GRM6GRIN2D
SCHEMBL5697661 0.84 KIF11 (0.50) KIF11GSRGRM8GRM6GRIN2D
SCHEMBL8418914 0.84 KIF11 (0.50) KIF11GSRGRM8GRM6GRIN2D
SCHEMBL25661140 0.82 NOS2 (0.51) KIF11GSRGRM8GRM6GRIN2D
SCHEMBL25661068 0.82 NOS2 (0.51) KIF11GSRGRM8GRM6GRIN2D
Hydrochloric Acid SCHEMBL29213474 0.82 NOS2 (0.50) KIF11GSRGRM8GRM6GRIN2D
SCHEMBL25660541 0.82 NOS2 (0.51) KIF11GSRGRM8GRM6GRIN2D
Hydrochloric Acid SCHEMBL319257 0.82 NOS2 (0.50) KIF11GSRGRM8GRM6GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017136581-A1 ANTI-EGFR ANTIBODY DRUG CONJUGATE MEDITOPE BIOSCIENCES, INC. (US) 2017-08-10 WO disclosed